Virtual peer mentoring aims to boost cervical cancer screening in ethiopian HIV clinics
NCT ID NCT07678047
First seen Jul 01, 2026 · Last updated Jul 01, 2026
Summary
This study tests whether a virtual training and peer-mentoring program called Project ECHO can help healthcare providers in Ethiopia improve cervical cancer screening and treatment for women living with HIV. The program focuses on using HPV self-sampling, a simpler screening method. Researchers will compare screening and treatment rates before and after the training to see if it makes a difference.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Project ECHO (virtual training and peer-mentoring program)
What this could lead to
If successful, this approach could improve cervical cancer screening and treatment rates for women with HIV in low-resource settings, potentially saving lives.
What could go wrong
This is a small, early-stage implementation study with only 60 participants, so results may not apply broadly. The training program may not lead to lasting changes in clinical practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Addis Ababa University
Addis Ababa, Ethiopia